Compound 1517
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2F)c1=O
- InChi:
InChI=1S/C21H12F5N5O/c1-30-19-13(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)21(24,25)26)20(32)31(29-18)15-6-5-12(22)8-14(15)23/h2-9,29H,1H3
- InChiKey:
QFNNZSZXUULFCW-UHFFFAOYSA-N
External links
![]() 168317956 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 445.10 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.28 | |||
TPSA | 63.05 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4750 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4750 | Riociguat | DB08931 | |
0.4677 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4612 | Dilmapimod | DB12140 | |
0.4597 | Vericiguat | DB15456 | |
0.4542 | ATX-914 | DB12673 | |
0.4530 | Tepotinib | DB15133 | |
0.4496 | Risdiplam | DB15305 | |
0.4493 | Decoglurant | DB11923 | |
0.4475 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4465 | MK-0249 | DB11910 | |
0.4392 | Merestinib | DB12381 | |
0.4378 | Ravoxertinib | DB15281 | |
0.4286 | ABT-288 | DB15192 | |
0.4195 | Neflamapimod | DB07138 |